Agopton 30 mg
Agopton 30 mg is a medicine authorised by Swissmedic under authorisation number 51969. The authorisation holder is Takeda Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 18 June 1993 and the authorisation is valid without a time limit. ATC code A02BC03 places the medicine in the group Drugs for acid related disorders.
| Authorisation number | 51969 |
|---|---|
| Name | Agopton 30 mg |
| Full name | Agopton 30 mg, magensaftresistente Hartkapseln |
| Authorisation holder | Takeda Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | A02BC03 |
| First authorisation | 18 June 1993 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Agopton 30 mg, magensaftresistente Hartkapseln | B | 18 June 1993 |
| 2 | Agopton 15 mg, magensaftresistente Hartkapseln | B | 11 September 1995 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 14 | 14 | Kapsel(n) | A02BC03 | 04.99.0. | B |
| 22 | 28 | Kapsel(n) | A02BC03 | 04.99.0. | B |
| 30 | 56 | Kapsel(n) | A02BC03 | 04.99.0. | B |
| 49 | 14 | Kapsel(n) | A02BC03 | 04.99.0. | B |
| 57 | 28 | Kapsel(n) | A02BC03 | 04.99.0. | B |
| 65 | 56 | Kapsel(n) | A02BC03 | 04.99.0. | B |
| 73 | 112 | Kapsel(n) | A02BC03 | 04.99.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Agopton 30 mg authorised in Switzerland?
Yes. Agopton 30 mg is authorised by Swissmedic under authorisation number 51969, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Agopton 30 mg have?
Agopton 30 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Agopton 30 mg?
The authorisation holder is Takeda Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.